The Dodgers hit into one of the most bizarre plays I’ve ever seen in baseball, let alone postseason baseball, in Game 1 of the NLCS. Batting with the bases loaded in the fourth inning, Max Muncy drove ...

These investments are WSP’s first add-ons Riverside invested in WSP in February WSP is an online training platform for financial professionals The Riverside Company-backed Wall Street Prep (WSP) has ...

Intellia Therapeutics has two promising late-stage pipeline candidates. The biotech has incredible hopes for these two medicines. However, its projections look too optimistic, and the stock carries ...

Intellia Therapeutics has two promising late-stage pipeline candidates. The biotech has incredible hopes for these two medicines. However, its projections look too optimistic, and the stock carries ...

KANSAS CITY, Kan. — Zane Smith was uninjured in a wild ride as his car slid on its side along the Kansas Speedway backstretch wall before flipping twice and landing on its wheels. John Hunter Nemechek ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Famous tech analyst Gene Munster, did some simple math.

Defendants in the $10 billion defamation lawsuit filed by President Donald Trump against Rupert Murdoch and the Wall Street Journal over a story about the U.S. president and Jeffrey Epstein have ...

YouTube ad revenue increased by double digits in the second quarter, helping parent Alphabet beat Wall Street estimates. Total revenue for the period ended June 30 climbed 14% over the year-ago ...

The Cincinnati Reds claimed Ryan Vilade off waivers June 14 and promoted him from Triple-A Louisville when they put Connor Joe on the IL. Vilade made his Reds' debut against the San Diego Padres at ...

We may earn commission from links on this page, but we only recommend products we love. Promise. When I think of the recliners I grew up with, “chic” is not the word that I would use to describe them.

CRISPR Therapeutics stock is down more than 80% from the peak it reached in 2021. The first drug from CRISPR Therapeutics launched early last year, but annualized sales are still less than $60 million ...